TiGenix
Local treatments for damaged and osteoarthritic joints.
Launch date
Market cap
-
Enterprise valuation
€520m (Public information from Jul 2018)
Company register number 0471.340.123
Leuven Flemish Brabant (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|
| Revenues | 2.0m | 2.0m | <1m | 2.0m |
| % growth | - | - | (60 %) | 150 % |
| EBITDA | - | (10.0m) | (6.0m) | (8.0m) |
| % EBITDA margin | - | (500 %) | (750 %) | (400 %) |
| R&D budget | - | - | 30.0m | - |
| R&D % of revenue | - | - | 3750 % | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
€12.0m | Early VC | ||
* | N/A | N/A | IPO |
| N/A | $7.5m | Post IPO Equity | |
* | $8.6m | Post IPO Equity | |
| N/A | €6.5m | Private Placement VC | |
| N/A | €12.0m | Private Placement VC | |
| N/A | €8.7m | Post IPO Equity | |
| N/A | N/A | IPO | |
* | €520m Valuation: €520m 650.0x EV/LTM Revenues -86.7x EV/LTM EBITDA | Acquisition | |
| Total Funding | €30.5m | ||
